Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Nanogen Receives Award for 5–Year Growth Record Second Year in Deloitte’s Technology Fast 50

Abstract:
Nanogen, Inc. (Nasdaq:NGEN), developer of molecular and rapid in vitro diagnostic products, has been named one of Deloitte's Technology Fast 50 in San Diego.

Nanogen Receives Award for 5–Year Growth Record Second Year in Deloitte’s Technology Fast 50

San Diego, CA | Posted on October 15th, 2008

The Technology Fast 50 comprises the 50 fastest-growing technology, media, telecommunications and life sciences companies in the San Diego area. Companies ranked in the list will also be highlighted in Deloitte's North American Technology Fast 500 composite list. Nanogen came in as San Diego's 17th fastest growing technology company on the list with a 468% CAGR over the past five years.

"We are proud to be named for a second year as one of Deloitte's Technology Fast 50," said David Ludvigson, President and Chief Operating Officer for Nanogen. "We have made great strides focusing on our core diagnostic products and developing new partnerships that have resulted in continuing rapid growth."

Nanogen has introduced industry-leading diagnostic tools for two of the fastest growing in vitro diagnostic (IVD) markets—molecular diagnostics and point-of-care rapid testing. The company's products include rapid diagnostic tests for cardiovascular diseases, such as myocardial infarction and congestive heart failure, and DNA or RNA tests for specific infectious diseases. The company has a strong intellectual proprietary portfolio, including their minor groove binder (MGB) technology which has been widely licensed in molecular biology fields and has proven to provide better results than traditional PCR probe technology.

In August, Nanogen announced its intention to merge with The Elitech Group, a private diagnostics company based in France. The combination will create a global IVD provider of products spanning the molecular, point-of-care, clinical chemistry and microbiology diagnostics markets with expected first year revenues of more than $150 million. This year's ranking is based on 2003 - 2007 numbers and does not reflect the company's 2008 performance or the prospective merger.

"To rank on Deloitte's Technology Fast 50, companies must have phenomenal revenue growth over five years," said Theresa Drew, managing partner, San Diego Practice, Deloitte & Touche LLP. "Nanogen has proven to be one of the fast-growth success stories in San Diego and we applaud their dedication to making their vision a reality."

####

About Nanogen, Inc.
Nanogen provides innovative, high-quality diagnostic products to clinicians, physicians and researchers worldwide, making it easier to predict, diagnose and, ultimately, help treat disease in a timely fashion. The company's products include molecular diagnostic kits and reagents and kits for rapid, point-of-care diagnostic tests. Nanogen has pioneered research in areas involving nanotechnology, biomarkers, and molecular biology to bring better results to diagnostics and healthcare.

For more information, please click here

Contacts:
Nanogen, Inc.
Kelly Gann
Marketing Communications
858-410-4667

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Iranian Researchers Synthesize Stable Ceramic Nanopowders at Room Temperature September 20th, 2014

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

Nanomedicine

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

The Pocket Project will develop a low-cost and accurate point-of-care test to diagnose Tuberculosis: ICN2 holds a follow-up meeting of the Project on September 18th - 19th September 18th, 2014

New non-invasive technique could revolutionize the imaging of metastatic cancer September 17th, 2014

Recruiting bacteria to be technology innovation partners: September 17th, 2014

Announcements

Iranian Scientists Separate Zinc Ion at Low Concentrations September 20th, 2014

Arrowhead to Present at BioCentury's NewsMakers in the Biotech Industry Conference September 19th, 2014

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Toward optical chips: A promising light source for optoelectronic chips can be tuned to different frequencies September 19th, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

SouthWest NanoTechnologies (SWeNT) Receives NIST Small Business Innovation Research (SBIR) Phase 1 Award to Produce Greater than 99% Semiconducting Single-Wall Carbon Nanotubes September 19th, 2014

Big Results Require Big Ambitions: Three young UCSB faculty receive CAREER awards from the National Science Foundation September 18th, 2014

Effective Nanotechnology Innovations to Receive Mustafa Prize September 16th, 2014

‘Small’ transformation yields big changes September 16th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE